1Gessner R,Tauber R,Intestinal cell adhesion molecules,liver-intes- tine cadherin[J]. Ann NY Acad Sci, 000,915:136-143.
2. Crosier PS,Bardsley A,Horsfield JA,et al. An in situ hybridization screen in zebrafish for the selection of genes encoding secreted pro- teins[J]. Dev Dyn, 02,222 (4):637-644.
3Kreft B, Bemdorff D, B?ttinger A, et al. LI-cadherin-mediated cell- cell adhesion does not require cytoplsmic interactions[J]. J Cell Bi- o1,1997,136(5):1109-1121.
4Bremnes RM,Veve R,Cabrielson E,et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic signifi- cance of the E-cadherin pathway in non-small-cell lung cancer[J]. J Clin Oncol, 2002,20(10):2417-2418.
5Mizoshita T, Tsukamoto T, Inada K, et al. Immunohistochemically de- tectable CDX-2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to nonneopalstic surrounding mueosa [J]. Pathol Int, 2004,54 (6) :392-400.
6Ko S, Chu KM, Luk JM, et al. Overexpression of LI-cadherin in gastric cancer is associated with lymph node matastasis[J]. Biochem Biophy Res Comm, 2004,319(2):562-568.
8Wang J, Kang WM, Yu JC, et al. Cadherin-17 induces tumorigenesis and lymphatic matastasis in gastric cancer through activation of NF- κB signaling pathway[J]. Cancer Biol Ther, 2013,14 (3) :262-270.
9Wang X Q, Luk J M, Leung P P, et al. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma[J]. Clin Cancer Res, 2005,15,1 1 (2Ptl):483-489.
10Lee NP, Poon RT, Shek FH, et al. Role of cadherin-17 in oncoge- nesis and potential therapeutic implications in hepatocelluar carci- noma[J]. Biochim Biophys Acta, 2010, 1806 ( 2 ): 138-145.